JSMO 公益社団法人 日本臨床腫瘍学会






Annals of Oncology賞
氏名 ご所属 対象論文
山崎 健太郎 静岡県立静岡がんセンター 消化器内科

Oxaliplatin-based adjuvant chemotherapy duration (3 versus 6 months) for high-risk stage II colon cancer: the randomized phase III ACHIEVE-2 trial


氏名 ご所属 演題名
興梠 慧輔 千葉大学大学院医学研究院 消化器内科学 Phase Ib trial of durvalumab plus tremelimumab with particle therapy in HCC with macrovascular invasion: DEPARTURE tria
橋本 直佳 国立がん研究センター東病院 消化管内科 The utility of circulating tumor DNA in gastrointestinal stromal tumor -a pooled analysis of SCRUM-Japan trials-
藤本 大智 和歌山県立医科大学附属病院 内科学第三講座 Prediction of prognosis in stage 4 lung cancer using machine learning: A multicenter cohort study (WJOG15121L:REAL-WIND)
森 啓一郎 東京慈恵会医科大学 泌尿器科 Catalog of preoperative blood-based biomarkers in patients treated with radical cystectomy for bladder carcinoma
山口 覚博 広島大学病院 呼吸器内科 Prospective observational study to identify a predictive blood marker for checkpoint inhibitor pneumonitis (CS-Lung 004)
山口 享子 九州大学病院 血液・腫瘍・心血管内科 Efficacy of Pembrolizumab in metastatic colorectal cancer with TMB-High/non-MSI-high
Se Ik Kim Department of Obsetetrics and Gynecology,
Seoul National University College of Medicine
Predicting therapeutic response to PARP inhibitors in high-grade serous ovarian cancer: A Comprehensive proteomics study
Yung-Yeh Su National Institute of Cancer Research,
National Health Research Institutes, Tainan, Taiwan
Chemoradiation Augments Gemcitabine in HRD-Positive Pancreatic Cancer: Results from A Randomized Adjuvant Trial
Wan-Ming Chen Graduate Institute of Business Administration,
College of Management, Fu Jen Catholic University, Taipei, Taiwan
Effects of SGLT2 Inhibitors on Clinical Cancer Survival